Please note: A registration confirmation will be sent to this e-mail address.
By providing your mobile phone number, you agree to receive a text message reminder for this activity. Standard text messaging rates may apply. 
0
1 to 5
6 to 10
11 to 15
greater than 15
Not at all confident
Somewhat confident
Moderately confident
Very confident
Completely confident
Never
Rarely
Sometimes
Very often
Always
Decrease immunosuppressive therapy
Begin IV foscarnet 90 mg/kg every 12 hours
Begin IV ganciclovir 5 mg/kg every 12 hours
Begin IV acyclovir 10 mg/kg every 8 hours
Increase immunosuppressive therapy
Perform genotypic assay for UL54 and UL97 mutations
Obtain serum drug levels of ganciclovir
Begin empiric treatment with cidofovir
Neuropathy
Myopathy
Hepatitis
Pancytopenia
Continue high-dose ganciclovir and obtain specimen from her lung
Discontinue high-dose ganciclovir and begin foscarnet
Discontinue high-dose ganciclovir and begin cidofovir
Discontinue high-dose ganciclovir and begin leflunomide

 

 

 

If you have any questions, please call (866)770-RMEI.
* Required field
(type NA if not applicable)
To read the RMEI Medical Education, LLC Privacy Policy, click here.